rituximab

English

Alternative forms

IDEC-C2B8

Etymology

From [Term?] +‎ -tu- (“tumor”) +‎ -ximab (“chimeric monoclonal antibody”).

Pronunciation

(General American) IPA^(key): /ɹɪˈtʌk.sɪˌmæb/

Noun

rituximab (usually uncountable, plural rituximabs)

(pharmacology) A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis.

References

“rituximab”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.

Spanish

Pronunciation

IPA^(key): /rituɡsiˈmab/ [ri.t̪uɣ̞.siˈmaβ̞]
Rhymes: -ab
Syllabification: ri‧tu‧xi‧mab

Noun

rituximab f (plural rituximabs)

(organic chemistry) rituximab

This article is issued from Wiktionary. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.